Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient

博茨瓦纳-宾夕法尼亚大学:HIV 患者 HPV 相关宫颈癌研究联盟

基本信息

  • 批准号:
    10834480
  • 负责人:
  • 金额:
    $ 6.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract: The cervical cancer burden in low and middle income countries make up about 80% of the total cervical cancer incidence worldwide. In Botswana the link between increased incidences of cervical cancer in HIV positive women has not been carefully explored. Furthermore there is an increased link between infectious disease and cancer as seen by additional recent studies including the presence of Merkel Cell Carcinomas with Merkel Cell Polyoma virus. This underscores the importance of these agents and their contributions to the oncogenic process. Greater than 20% of human cancers are associated with infectious agents and that estimate is likely to be lower than the actual number. The advances in technology and approaches which include recovery of nucleic acids from tissues and other materials has greatly improved our ability to detect and confirm the identifications of these agents in associated cancers. The overall goal of the proposed studies in project #1 is to determine the contributions of infectious agents to development of cervical carcinomas in HIV positive women in Botswana. This dramatic increase in cervical cancer incidence in HIV positive women in Botswana allows for the potential contributions of additional agents as well as the inflammatory response which together leads to a more rapid and proliferative response. Our project will take advantage of our unique cohorts of women in Bostwana that allows us to monitor changes in the cervical flora from HPV and HIV negative women to women with cervical cancer who are HIV and HPV positive. Our initial question will be to identify additional agents which may be linked to development of cervical carcinomas in this population. Our working hypothesis is that multiple agents can contribute to the development of cervical carcinomas in HIV positive women in Botswana and this can result in an inflammatory response which synergistically leads to cervical carcinomas. We will utilize our newly developed combinatorial strategy which bridges microarray technology with high throughput sequencing. The identification of these agents will be followed by validation of the presence of these agents in tissues, transcription analysis of infected cells as well as analysis of the innate and adaptive inflammatory responses with the associated agents, and investigating the proliferative effects on these cells.
摘要: 低收入和中等收入国家的子宫颈癌负担约占子宫颈癌总负担的80%。 全球癌症发病率。在博茨瓦纳,#年宫颈癌发病率增加之间的联系 艾滋病毒阳性妇女还没有得到仔细的研究。此外,两者之间的联系也在增加 最近的其他研究,包括默克尔细胞的存在,发现了传染病和癌症 默克尔细胞多瘤病毒致癌。这突显了这些代理人和他们的 对致癌过程的贡献。超过20%的人类癌症与 这一估计很可能低于实际数字。新技术的进展 包括从组织和其他材料中回收核酸的技术和方法已经 极大地提高了我们在相关癌症中检测和确认这些病原体的能力。 项目1中拟议研究的总体目标是确定感染性病原体的作用。 与博茨瓦纳艾滋病毒阳性妇女宫颈癌的发生有关。这种戏剧性的增长 博茨瓦纳艾滋病毒阳性妇女的宫颈癌发病率允许潜在的 其他制剂以及炎症反应共同导致更迅速和 增殖反应。我们的项目将利用我们在Bostwana的独特女性队列 使我们能够监测从HPV和HIV阴性的妇女到患有HPV和HIV的妇女宫颈菌群的变化 HIV和HPV阳性的宫颈癌患者。我们最初的问题将是确定更多的代理 这可能与这一人群中宫颈癌的发生有关。我们的工作假设是 多种因素可能导致艾滋病毒阳性妇女宫颈癌的发生 博茨瓦纳,这会导致炎症反应,协同作用导致宫颈 癌症。我们将利用我们最新开发的组合策略来桥接微阵列 高通量测序技术。在确定这些代理之后,将 确认这些病原体在组织中的存在,感染细胞的转录分析以及 与相关因素相关的先天和获得性炎症反应的分析和调查 对这些细胞的增殖作用。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana.
  • DOI:
    10.1200/jgo.18.00088
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bhatia RK;Rayne S;Rate W;Bakwenabatsile L;Monare B;Anakwenze C;Dhillon P;Narasimhamurthy M;Dryden-Peterson S;Grover S
  • 通讯作者:
    Grover S
Breast Cancer and HIV in Sub-Saharan Africa: A Complex Relationship.
  • DOI:
    10.1200/jgo.2016.006585
  • 发表时间:
    2018-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Grover S;Martei YM;Puri P;Prabhakar P;Mutebi M;Balogun OD;Price AJ;Freeman AH;Narasimhamurthy M;Rodin D;Rayne S;Zetola NM
  • 通讯作者:
    Zetola NM
Norms and beliefs related to cervical cancer screening amongst women aged 25-49 in Botswana: A pilot study.
博茨瓦纳 25-49 岁女性宫颈癌筛查相关规范和信念:一项试点研究。
  • DOI:
    10.1016/j.ijans.2018.11.001
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Major,Thenjiwe;Koyabe,Bramell;Ntsayagae,Esther;Monare,Barati;Molwane,Olefile;Gabaitiri,Lesego
  • 通讯作者:
    Gabaitiri,Lesego
Cervical cancer control in HIV-infected women: Past, present and future.
  • DOI:
    10.1016/j.gore.2017.07.009
  • 发表时间:
    2017-08
  • 期刊:
  • 影响因子:
    1.2
  • 作者:
    Ghebre RG;Grover S;Xu MJ;Chuang LT;Simonds H
  • 通讯作者:
    Simonds H
Organ-Specific Toxicities Due to Radiation Therapy in Cancer Patients With or Without HIV Infection: A Systematic Review of the Literature.
有或没有 HIV 感染的癌症患者因放射治疗而产生的器官特异性毒性:文献的系统回顾。
  • DOI:
    10.3389/fonc.2018.00276
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Xu,MelodyJ;Liewen,Alison;Valle,Luca;Olson,AdamC;Zetola,NicolaM;Grover,Surbhi
  • 通讯作者:
    Grover,Surbhi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERLE S. ROBERTSON其他文献

ERLE S. ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERLE S. ROBERTSON', 18)}}的其他基金

Project 1: KSHV reprograms replication and metabolic activities in hypoxia
项目 1:KSHV 在缺氧条件下重新编程复制和代谢活动
  • 批准号:
    10714173
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Transcription and Replication of Oncogenic Viruses in Hypoxia
缺氧条件下致癌病毒的转录和复制
  • 批准号:
    10714172
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Virus, Vector and Cell Culture Core
病毒、载体和细胞培养核心
  • 批准号:
    10714178
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10714177
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
项目2:KSHV利用缺氧条件下的分化诱导肿瘤发生
  • 批准号:
    10714174
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Next Generation Sequencing Core
下一代测序核心
  • 批准号:
    10714179
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
  • 批准号:
    10402055
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
  • 批准号:
    10684650
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
  • 批准号:
    10457380
  • 财政年份:
    2019
  • 资助金额:
    $ 6.93万
  • 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
  • 批准号:
    9978759
  • 财政年份:
    2019
  • 资助金额:
    $ 6.93万
  • 项目类别:

相似海外基金

Youth co-design prevention of gendered personal and interpersonal violence in Botswana
博茨瓦纳青年共同设计预防性别个人和人际暴力
  • 批准号:
    495126
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
    Operating Grants
Unpacking the dynamics of how women's multiple partnerships are prevalent and inheritance among Kgatla populations in Botswana
揭示博茨瓦纳 Kgatla 人群中女性多重伴侣关系如何普遍存在以及遗传的动态
  • 批准号:
    22KJ1923
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Admin Sup FACET: Family Dynamics and Child Neurodevelopment in Botswana
Admin Sup FACET:博茨瓦纳的家庭动态和儿童神经发育
  • 批准号:
    10766920
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Microbial Survival in the Makgadikgadi Basin, Botswana
博茨瓦纳马卡迪卡迪盆地的微生物生存
  • 批准号:
    2824002
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
    Studentship
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
博茨瓦纳早期治疗儿童中三种广泛中和抗体和分析治疗中断的临床试验
  • 批准号:
    10764517
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
Developing Botswana Laboratory Capacity in HIV Genomics and HIV Cure
发展博茨瓦纳艾滋病毒基因组学和艾滋病毒治疗实验室能力
  • 批准号:
    10688320
  • 财政年份:
    2023
  • 资助金额:
    $ 6.93万
  • 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
  • 批准号:
    10650820
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
  • 批准号:
    10705316
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana
Thibang Diphatlha:测试适应性策略,以缩小博茨瓦纳从宫颈癌诊断到治疗的差距
  • 批准号:
    10844698
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
  • 批准号:
    10925898
  • 财政年份:
    2022
  • 资助金额:
    $ 6.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了